Learn more →
Back to Expert Scholars
basic / basicCancer Epigenomics

Cigall Kadoch

西加尔·卡多奇

PhD

🏢Dana-Farber Cancer Institute / Broad Institute of MIT and Harvard(达纳-法伯癌症研究所 / 博德研究所)🌐USA

Associate Professor of Pediatric Oncology; Broad Institute Core Member儿科肿瘤学副教授;博德研究所核心成员

52
h-index
3
Key Papers
4
Awards
3
Key Contributions

👥Biography 个人简介

Cigall Kadoch is the world's leading authority on the SWI/SNF (BAF) chromatin remodeling complex in cancer. She discovered the molecular mechanism of synovial sarcoma driven by SS18-SSX fusion and has systematically characterized how SWI/SNF subunit mutations drive ~20% of all human cancers, pioneering targeted epigenetic therapies.

Share:

🧪Research Fields 研究领域

SWI/SNF Chromatin Remodeling ComplexSWI/SNF染色质重塑复合物
SMARCA4/SMARCB1 MutationsSMARCA4/SMARCB1突变
Synovial Sarcoma滑膜肉瘤
Epigenetic Therapy表观遗传治疗
BAF Complex BiologyBAF复合物生物学

🎓Key Contributions 主要贡献

SWI/SNF Complex Mechanism in Synovial Sarcoma

Discovered that the SS18-SSX oncofusion hijacks BAF complexes, evicting SMARCB1 and retargeting the complex to activate oncogenic gene programs, providing the first mechanistic model for synovial sarcoma.

SWI/SNF Mutations Across Cancer Types

Comprehensively catalogued SWI/SNF subunit mutations in ~20% of human cancers and established structure-function relationships explaining how specific subunit losses drive distinct malignancies.

Synthetic Lethality in SWI/SNF-Mutant Cancers

Identified PRC2 dependency as a synthetic lethal vulnerability in SMARCB1-deficient cancers, providing the mechanistic rationale for EZH2 inhibitor use in rhabdoid tumors and epithelioid sarcoma.

Representative Works 代表性著作

[1]

Proteomic and genomic approaches reveal critical functions of H3K27 methylation and BRD4 in pediatric rhabdoid tumor cells

Nature Genetics (2015)

Revealed PRC2-SWI/SNF antagonism as a key regulatory axis exploitable for therapy in SMARCB1-deficient tumors.

[2]

Functional and mechanistic landscape of the mammalian SWI/SNF complex in cancer

Nature Reviews Cancer (2022)

Comprehensive review detailing the biochemical diversity of BAF complexes and the spectrum of their oncogenic alterations.

[3]

SS18-SSX2 fusion oncoprotein mediates direct recruitment of the BAF complex to gene promoters

Cell (2013)

Determined that SS18-SSX drives BAF complex mistargeting, providing the molecular basis for synovial sarcoma tumorigenesis.

🏆Awards & Recognition 奖项与荣誉

🏆Presidential Early Career Award for Scientists and Engineers (PECASE)
🏆American Cancer Society Research Scholar
🏆Damon Runyon-Rachleff Innovation Award
🏆Rita Allen Foundation Scholar

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 西加尔·卡多奇 的研究动态

Follow Cigall Kadoch's research updates

留下邮箱,当我们发布与 Cigall Kadoch(Dana-Farber Cancer Institute / Broad Institute of MIT and Harvard)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment